Niagen Bioscience, Inc. (NAGE)

NASDAQ: NAGE · Real-Time Price · USD

3.020

-0.030 (-0.98%)

At close: Aug 14, 2026, 4:00 PM EDT

3.040

+0.020 (0.66%)

After-hours: Aug 14, 2026, 7:42 PM EDT

Niagen Bioscience Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	129.08	129.42	99.6	83.57	72.05	67.45
Revenue Growth	10.99%	29.95%	19.18%	15.99%	6.82%	13.83%
Cost of Revenue	46.16	46.23	38.01	32.79	29.25	25.96
Gross Profit	82.92	83.19	61.59	50.78	42.8	41.49
Selling, General & Admin	67.81	62.56	47.84	51.42	56.6	64.73
Research & Development	6.5	6.33	6.02	4.96	4.83	3.83
Operating Expenses	74.31	68.89	53.86	56.38	61.43	68.56
Operating Income	8.62	14.3	7.73	-5.6	-18.63	-27.07
Interest Expense	-	-	-	-	-	-0.06
Interest & Investment Income	1.86	2.13	1.13	0.66	0	-
Other Non Operating Income (Expenses)	-0.21	-0.21	-	-	-	-
EBT Excluding Unusual Items	10.26	16.21	8.86	-4.94	-18.63	-27.13
Other Unusual Items	1.98	1.98	-	-	2.09	-
Pretax Income	17.03	18.19	8.86	-4.94	-16.54	-27.13
Income Tax Expense	1.04	0.81	0.31	-	-	-
Earnings From Continuing Operations	15.99	17.38	8.55	-4.94	-16.54	-27.13
Net Income	15.99	17.38	8.55	-4.94	-16.54	-27.13
Net Income to Common	15.99	17.38	8.55	-4.94	-16.54	-27.13
Net Income Growth	-9.80%	103.30%	-	-	-	-
Shares Outstanding (Basic)	80	79	76	75	70	67
Shares Outstanding (Diluted)	85	85	78	75	70	67
Shares Change	2.25%	9.36%	4.19%	7.54%	3.79%	10.02%
EPS (Basic)	0.20	0.22	0.11	-0.07	-0.24	-0.40
EPS (Diluted)	0.19	0.20	0.11	-0.07	-0.24	-0.40
EPS Growth	-11.65%	81.82%	-	-	-	-
Free Cash Flow	5.67	13.21	11.95	6.97	-15.43	-24.57
Free Cash Flow Per Share	0.07	0.15	0.15	0.09	-0.22	-0.37
Gross Margin	64.24%	64.28%	61.83%	60.76%	59.40%	61.51%
Operating Margin	6.67%	11.05%	7.76%	-6.70%	-25.85%	-40.14%
Profit Margin	12.39%	13.43%	8.58%	-5.91%	-22.96%	-40.22%
Free Cash Flow Margin	4.40%	10.21%	11.99%	8.34%	-21.42%	-36.43%
EBITDA	9.59	15.08	8.54	-4.57	-17.57	-25.96
EBITDA Margin	7.43%	11.65%	8.58%	-5.47%	-24.39%	-38.48%
D&A For EBITDA	0.98	0.79	0.81	1.03	1.06	1.12
EBIT	8.62	14.3	7.73	-5.6	-18.63	-27.07
EBIT Margin	6.67%	11.05%	7.76%	-6.70%	-25.85%	-40.14%
Effective Tax Rate	6.09%	4.45%	3.44%	-	-	-
Advertising Expenses	-	12.66	11.1	10.3	11.4	12.5

SEC Filings: 10-K · 10-Q